ATEC vs. IART, ATRC, OFIX, OSUR, TCMD, GMED, TNDM, LMAT, NARI, and NVCR
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Integra LifeSciences (IART), AtriCure (ATRC), Orthofix Medical (OFIX), OraSure Technologies (OSUR), Tactile Systems Technology (TCMD), Globus Medical (GMED), Tandem Diabetes Care (TNDM), LeMaitre Vascular (LMAT), Inari Medical (NARI), and NovoCure (NVCR). These companies are all part of the "surgical & medical instruments" industry.
Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.
In the previous week, Integra LifeSciences had 2 more articles in the media than Alphatec. MarketBeat recorded 5 mentions for Integra LifeSciences and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.22 beat Integra LifeSciences' score of -0.31 indicating that Alphatec is being referred to more favorably in the media.
Integra LifeSciences has a net margin of 4.39% compared to Alphatec's net margin of -38.70%. Integra LifeSciences' return on equity of 15.19% beat Alphatec's return on equity.
Integra LifeSciences has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.
Alphatec presently has a consensus price target of $23.63, indicating a potential upside of 91.45%. Integra LifeSciences has a consensus price target of $44.89, indicating a potential upside of 49.18%. Given Alphatec's stronger consensus rating and higher probable upside, analysts plainly believe Alphatec is more favorable than Integra LifeSciences.
Integra LifeSciences received 123 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 58.39% of users gave Integra LifeSciences an outperform vote while only 56.52% of users gave Alphatec an outperform vote.
66.4% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 29.1% of Alphatec shares are held by company insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Alphatec has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.
Summary
Integra LifeSciences beats Alphatec on 11 of the 18 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
